BTG (BTG) Competitors

BTG logo
GBX 113.50 +0.50 (+0.44%)
As of 11/16/2026 11:57 AM Eastern

BTG vs. SLP, TRX, EGI, IMG, and NGR

Should you buy BTG stock or one of its competitors? BTG's main competitors and comparable companies include Sylvania Platinum (SLP), Tissue Regenix Group (TRX), (EGI.L) (EGI), 532753 (IMG.L) (IMG), and Nature Group (NGR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "precious metals & minerals" industry.

How does BTG compare to Sylvania Platinum?

BTG (LON:BTG) and Sylvania Platinum (LON:SLP) are both small-cap materials companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations and profitability.

In the previous week, BTG had 3 more articles in the media than Sylvania Platinum. MarketBeat recorded 4 mentions for BTG and 1 mentions for Sylvania Platinum. Sylvania Platinum's average media sentiment score of 0.59 beat BTG's score of -0.08 indicating that Sylvania Platinum is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BTG
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Sylvania Platinum
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Sylvania Platinum has a net margin of 29.28% compared to BTG's net margin of 0.00%. Sylvania Platinum's return on equity of 22.65% beat BTG's return on equity.

Company Net Margins Return on Equity Return on Assets
BTGN/A N/A N/A
Sylvania Platinum 29.28%22.65%1.69%

BTG pays an annual dividend of GBX 4.40 per share and has a dividend yield of 3.9%. Sylvania Platinum pays an annual dividend of GBX 5.33 per share and has a dividend yield of 6.4%. BTG pays out 86.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Sylvania Platinum pays out 20.8% of its earnings in the form of a dividend. Sylvania Platinum is clearly the better dividend stock, given its higher yield and lower payout ratio.

BTG presently has a consensus price target of GBX 160.33, suggesting a potential upside of 41.26%. Sylvania Platinum has a consensus price target of GBX 156.50, suggesting a potential upside of 88.55%. Given Sylvania Platinum's higher possible upside, analysts plainly believe Sylvania Platinum is more favorable than BTG.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BTG
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Sylvania Platinum
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

19.5% of BTG shares are held by institutional investors. Comparatively, 17.7% of Sylvania Platinum shares are held by institutional investors. 19.7% of BTG shares are held by company insiders. Comparatively, 4.7% of Sylvania Platinum shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Sylvania Platinum has higher revenue and earnings than BTG. Sylvania Platinum is trading at a lower price-to-earnings ratio than BTG, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BTG£168.50M1.09N/A£5.1022.25
Sylvania Platinum£226.32M0.95£8.54M£25.663.23

Summary

Sylvania Platinum beats BTG on 9 of the 15 factors compared between the two stocks.

How does BTG compare to Tissue Regenix Group?

BTG (LON:BTG) and Tissue Regenix Group (LON:TRX) are both small-cap materials companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, institutional ownership, media sentiment and risk.

BTG has higher revenue and earnings than Tissue Regenix Group. Tissue Regenix Group is trading at a lower price-to-earnings ratio than BTG, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BTG£168.50M1.09N/A£5.1022.25
Tissue Regenix Group£27.75M0.00-£1.11M-£1.91N/A

In the previous week, BTG had 4 more articles in the media than Tissue Regenix Group. MarketBeat recorded 4 mentions for BTG and 0 mentions for Tissue Regenix Group. Tissue Regenix Group's average media sentiment score of 0.00 beat BTG's score of -0.08 indicating that Tissue Regenix Group is being referred to more favorably in the news media.

Company Overall Sentiment
BTG Neutral
Tissue Regenix Group Neutral

BTG currently has a consensus price target of GBX 160.33, indicating a potential upside of 41.26%. Given BTG's stronger consensus rating and higher probable upside, research analysts clearly believe BTG is more favorable than Tissue Regenix Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BTG
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Tissue Regenix Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

19.5% of BTG shares are owned by institutional investors. Comparatively, 0.0% of Tissue Regenix Group shares are owned by institutional investors. 19.7% of BTG shares are owned by company insiders. Comparatively, 6.9% of Tissue Regenix Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

BTG has a net margin of 0.00% compared to Tissue Regenix Group's net margin of -2.49%. BTG's return on equity of 0.00% beat Tissue Regenix Group's return on equity.

Company Net Margins Return on Equity Return on Assets
BTGN/A N/A N/A
Tissue Regenix Group -2.49%-2.38%0.50%

Summary

BTG beats Tissue Regenix Group on 12 of the 14 factors compared between the two stocks.

How does BTG compare to (EGI.L)?

BTG (LON:BTG) and (EGI.L) (LON:EGI) are both materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk and media sentiment.

In the previous week, BTG had 4 more articles in the media than (EGI.L). MarketBeat recorded 4 mentions for BTG and 0 mentions for (EGI.L). (EGI.L)'s average media sentiment score of 0.00 beat BTG's score of -0.08 indicating that (EGI.L) is being referred to more favorably in the news media.

Company Overall Sentiment
BTG Neutral
(EGI.L) Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BTG£168.50M1.09N/A£5.1022.25
(EGI.L)N/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BTGN/A N/A N/A
(EGI.L) N/A N/A N/A

19.5% of BTG shares are held by institutional investors. 19.7% of BTG shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

BTG presently has a consensus target price of GBX 160.33, suggesting a potential upside of 41.26%. Given BTG's stronger consensus rating and higher possible upside, equities research analysts plainly believe BTG is more favorable than (EGI.L).

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BTG
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
(EGI.L)
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

BTG beats (EGI.L) on 7 of the 8 factors compared between the two stocks.

How does BTG compare to 532753 (IMG.L)?

BTG (LON:BTG) and 532753 (IMG.L) (LON:IMG) are both materials companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, profitability, valuation, risk, institutional ownership and dividends.

Company Net Margins Return on Equity Return on Assets
BTGN/A N/A N/A
532753 (IMG.L) N/A N/A N/A

19.5% of BTG shares are owned by institutional investors. 19.7% of BTG shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BTG£168.50M1.09N/A£5.1022.25
532753 (IMG.L)N/AN/AN/AN/AN/A

BTG currently has a consensus price target of GBX 160.33, suggesting a potential upside of 41.26%. Given BTG's stronger consensus rating and higher possible upside, equities analysts clearly believe BTG is more favorable than 532753 (IMG.L).

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BTG
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
532753 (IMG.L)
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, BTG had 4 more articles in the media than 532753 (IMG.L). MarketBeat recorded 4 mentions for BTG and 0 mentions for 532753 (IMG.L). 532753 (IMG.L)'s average media sentiment score of 0.00 beat BTG's score of -0.08 indicating that 532753 (IMG.L) is being referred to more favorably in the news media.

Company Overall Sentiment
BTG Neutral
532753 (IMG.L) Neutral

Summary

BTG beats 532753 (IMG.L) on 7 of the 8 factors compared between the two stocks.

How does BTG compare to Nature Group?

BTG (LON:BTG) and Nature Group (LON:NGR) are both materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations, media sentiment and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BTG£168.50M1.09N/A£5.1022.25
Nature GroupN/AN/AN/AN/AN/A

19.5% of BTG shares are owned by institutional investors. 19.7% of BTG shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

BTG presently has a consensus target price of GBX 160.33, indicating a potential upside of 41.26%. Given BTG's stronger consensus rating and higher possible upside, equities research analysts plainly believe BTG is more favorable than Nature Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BTG
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Nature Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Company Net Margins Return on Equity Return on Assets
BTGN/A N/A N/A
Nature Group N/A N/A N/A

In the previous week, BTG had 4 more articles in the media than Nature Group. MarketBeat recorded 4 mentions for BTG and 0 mentions for Nature Group. Nature Group's average media sentiment score of 0.00 beat BTG's score of -0.08 indicating that Nature Group is being referred to more favorably in the news media.

Company Overall Sentiment
BTG Neutral
Nature Group Neutral

Summary

BTG beats Nature Group on 7 of the 8 factors compared between the two stocks.

Get BTG News Delivered to You Automatically

Sign up to receive the latest news and ratings for BTG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BTG vs. The Competition

MetricBTGMetals & Mining IndustryMaterials SectorLON Exchange
Market Cap£183.52M£3.51B£4.60B£2.84B
Dividend Yield4.07%5.02%4.32%5.11%
P/E Ratio22.2525.4725.9823.37
Price / Sales1.098.785.855.05
Price / Cash9.2522.8320.8420.23
Price / Book0.324.323.992.51
Net IncomeN/A£127.64M£159.75M£5.88B
7 Day Performance0.89%-5.37%-4.45%-0.45%
1 Month Performance3.18%-9.35%-7.44%-2.23%
1 Year PerformanceN/A5.89%6.19%7.34%

BTG Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BTG
BTG
3.5385 of 5 stars
GBX 113.50
+0.4%
GBX 160.33
+41.3%
N/A£183.52M£168.50M22.254,690
SLP
Sylvania Platinum
4.5062 of 5 stars
GBX 85.95
+0.5%
GBX 156.50
+82.1%
-3.3%£221.58M£226.32M3.35160
TRX
Tissue Regenix Group
N/AGBX 0.07
flat
N/AN/A£52K£27.75MN/A120
EGI
(EGI.L)
N/AN/AN/AN/A£0.00N/AN/A6
IMG
532753 (IMG.L)
N/AN/AN/AN/A£0.00N/AN/A5,360

Related Companies and Tools


This page (LON:BTG) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners